Open AccessEffect of obesity on vedolizumab response in inflammatory bowel disease
Author(s) -
Louis Levine
Publication year - 2022
Publication title -
annals of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.886
H-Index - 33
eISSN - 1792-7463
pISSN - 1108-7471
DOI - 10.20524/aog.2022.0699
Subject(s) - vedolizumab , medicine , discontinuation , gastroenterology , body mass index , inflammatory bowel disease , retrospective cohort study , obesity , disease